- Udyam number
- UDYAM-TS-02-0003201

About Intron Life Sciences Private Limited
Data last updated:
Intron Life Sciences Private Limited is a private limited company based in Gundlapalli, Andhra Pradesh, India, a subsidiary of India Life Sciences Fund Iii, Llc. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 28 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24299AP2018PTC109365. Its GSTIN is 37AAFCI0026E1Z2 (Andhra Pradesh). The company holds 7 GST registrations, all of them active.
The company has an authorised share capital of ₹22.8 Cr and a paid-up capital of ₹20.32 Cr. It is led by directors including Sreemannarayana Murali Krishna Pasumarthi (Managing Director) and Pavan Kumar Velpuri (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.368 & 375 Apiic Industrial Growth Centre, Gundlapalli, Andhra Pradesh, India – 523211.
As per the financials filed for FY 2025, the company reported a revenue of ₹102.53 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹13.27 Cr (net margin 12.9%) and EBITDA of ₹23.75 Cr (EBITDA margin 23.2%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 20% over five years.
The company has about 194 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Intron Life Sciences. As per MCA filings, the company has open charges of ₹24 Cr and satisfied charges of ₹22 Cr on record. Court records list 45 cases involving the company, including 45 filed by the company; 43 cases are pending. The company has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹61.01 Cr; the latest was in October 2025.
Intron Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003201). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website intronlifesciences.com.
Company details
Recognitions & Rankings of Intron Life Sciences
Contact details
Intron Life Sciences Private Limited's registered office is in Gundlapalli, Andhra Pradesh. Its website is intronlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.368 & 375 Apiic Industrial Growth Centre, Gundlapalli, Andhra Pradesh, India – 523211
- IndustryLife Sciences, Biotechnology
To see the full contact details of Intron Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Intron Life Sciences operates one associated brand: Intron Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer and supplier of probiotics & biotech products | intronlifesciences.com |
Business activity
The main business activity of Intron Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Intron Life Sciences Private Limited, buy the company report.
Financials of Intron Life Sciences Private Limited
FY 2025 filings availableIntron Life Sciences Private Limited reported revenue of ₹102.53 Cr (up 32% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 32% growth in the latest year. EBITDA rose 178% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.75 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.27 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.2% | ||||
| Net Profit Margin | 12.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Intron Life Sciences Private Limited, buy the company report.
Board of directors of Intron Life Sciences Private Limited
Intron Life Sciences has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saranya Mukul Agrawal Also directs: Divyanshi Asset Management LLP, HHV Advanced Technologies Private Limited, Landcraft Retail Private Limited and 1 more | Nominee Director | 08 Oct 2025 | 1 Years 1 Months | Current |
| Sreemannarayana Murali Krishna Pasumarthi Also directs: Purplecow Foods Private Limited, Biome Biologicals Private Limited, Ipi India Private Limited and 3 more | Managing Director | 28 Sep 2018 | 8 Years 1 Months | Current |
| Pavan Kumar Velpuri Also directs: Purplecow Foods Private Limited, Biome Biologicals Private Limited, Exome Life Sciences Private Limited and 1 more | Whole-Time Director | 28 Sep 2018 | 8 Years 1 Months | Current |
| Vijay Ramvallabh Khetan | Nominee Director | 08 Oct 2025 | 1 Years 1 Months | Current |
| Manish Gupta | Nominee Director | 08 Oct 2025 | 1 Years 1 Months | Current |
Auditor
Intron Life Sciences Private Limited is audited by MSKA & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSKA & Associates | FY 2023 | 105047W |
Shareholding
The shareholding of Intron Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Intron Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2024 | 101041924 | Hdfc Bank Limited | ₹20.23 Lakh | Open | |
| 15 Nov 2023 | 100816777 | Hdfc Bank Limited | ₹20.85 Lakh | Open | |
| 09 Feb 2023 | 100707301 | Hdfc Bank Limited | ₹61 Lakh | Open | |
| 13 Jan 2023 | 100681962 | Axis Bank Limited | ₹22.3 Cr | Open | |
| 25 Apr 2022 | 100598477 | Hdfc Bank Limited | ₹68.3 Lakh | Open |
To see the full charge records of Intron Life Sciences Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Intron Life Sciences Private Limited has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹61.01 Cr; the latest was in October 2025.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2025 | Funding round | ₹10 Cr | Investors: Param Capital, an individual |
| Dec 2022 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Dec 2018 | Secondary share transfer | Undisclosed | Buyer: InvAscent Seller: an individual |
| Dec 2018 | Funding round | ₹51.01 Cr | Investors: InvAscent |
To see the full deal history of Intron Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Intron Life Sciences Private Limited has 45 court cases on record: 45 filed by Intron Life Sciences. 43 cases are pending and 2 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 44 | 0 | 43 |
| High courts | 1 | 0 | 0 |
Cases on record (5 of 45)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against M/S. Ananya Aqua Products. Rep by Pradepkumar Yogeshbhai Patel | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against A to Z Aqua Traders | Pending |
| District court, Rangareddy, Telangana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Intron Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Intron Life Sciences Private Limited was last rated by Care on 16 Jul 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 16 Jul 2021 |
To see the full credit ratings and regulatory alerts of Intron Life Sciences Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Intron Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Intron Life Sciences has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Biome Biologicals Private Limited | U24299TG2021PTC147890 |
To see the full group structure of Intron Life Sciences Private Limited, buy the company report.
Employees & EPFO
Intron Life Sciences Private Limited has a workforce of 194 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 194 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Intron Life Sciences Private Limited, buy the company report.
GST
Intron Life Sciences has 7 GST registrations: 7 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAFCI0026E1Z2 | Andhra Pradesh | Active | 28 Sep 2018 |
| 19AAFCI0026E1Z0 | West Bengal | Active | 28 Sep 2018 |
| 24AAFCI0026E1Z9 | Gujarat | Active | 28 Sep 2018 |
| 27AAFCI0026E1Z3 | Maharashtra | Active | 28 Sep 2018 |
To see the full GST registrations and return filing status of Intron Life Sciences Private Limited, buy the company report.
Recent activity
Intron Life Sciences Private Limited has 9 board changes on record since 2018: 5 appointments and 4 cessations. The latest: Manish Gupta was appointed as Nominee Director on 08 Oct 2025.
11 earlier events are in the company report.
Frequently asked questions
Intron Life Sciences is an active private limited company based in Gundlapalli, Andhra Pradesh, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 28 September 2018 (8+ years old) and is registered under CIN U24299AP2018PTC109365.
Intron Life Sciences has 5 current directors:
- Sreemannarayana Murali Krishna Pasumarthi - Managing Director
- Pavan Kumar Velpuri - Whole-Time Director
- Saranya Mukul Agrawal - Nominee Director
- Vijay Ramvallabh Khetan - Nominee Director
- Manish Gupta - Nominee Director
The latest financial statements of Intron Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Intron Life Sciences is 37AAFCI0026E1Z2, registered in Andhra Pradesh. The company has 7 GST registrations in all, of which 7 are active. Other active GSTINs include 19AAFCI0026E1Z0 (West Bengal), 24AAFCI0026E1Z9 (Gujarat), 27AAFCI0026E1Z3 (Maharashtra).
The CIN (Corporate Identification Number) of Intron Life Sciences is U24299AP2018PTC109365. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Intron Life Sciences has 45 court cases on record: 45 filed by the company. 43 are pending. Most are in the district courts.
Intron Life Sciences was incorporated on 28 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Vijayawada.
Intron Life Sciences has 6 deals on record (4 secondary share transfers, 2 funding rounds), with disclosed funding of ₹61.01 Cr; the latest was in October 2025.
Manish Gupta was appointed as Nominee Director on 08 Oct 2025. Nithyagovind ceased to be Director on 08 Oct 2025. Saranya Mukul Agrawal was appointed as Nominee Director on 08 Oct 2025. Intron Life Sciences has 9 board changes on record in total.
Yes, Intron Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0003201).

